Surgery benefits synchronous colorectal liver metastases with patients undergoing multimodality treatment

Abstract

discharge, and discharge destination were analyzed. Readmission rates at 30 days were analyzed using multivariate logistic regression models. Results: 2,202 patients met inclusion criteria. Median age was 74, 50.5% male. Readmission was 10.8% at 30 days. Demographics, Charlson comorbidity score, and education were not associated with readmission. LOS>10d was associated with increased readmission (OR = 1.73 [1.14,2.62]). Patients discharged to home had a decreased risk of readmission (OR = 0.55 [0.39,0.79]). Conclusions: This study represents preliminary work in examining readmission after treatment of colorectal liver metastases. Prolonged LOS and discharge to a non-home location carry an increased risk of readmission. Comorbidities and other patient factors did not influence readmission rate in the SEER-Medicare dataset, suggesting that standard demographic-based risk stratification may not be valid in this dataset. Additional research is needed to further elucidate and accurately predict causes of readmission.